Titan Pharmaceuticals, Inc.
IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES

Last updated:

Abstract:

Implants are described which comprise lipophilic pharmaceutical substances. Excipients are used which provide appropriate and controllable/tunable release of the lipophilic drug from the matrix of the implant. The implants can be implanted into a patient for release of the pharmaceutical substances. Methods of making and using such implants are also described.

Status:
Application
Type:

Utility

Filling date:

25 Jun 2019

Issue date:

22 Apr 2021